Erysipelas epidemiology and demographics
|
Erysipelas Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erysipelas epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Erysipelas epidemiology and demographics |
|
Risk calculators and risk factors for Erysipelas epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
Epidemiological and demographic information on erysipelas is not fully documented. Research in Belgium in 2004 approximated the incidence of erysipelas to be 249 per 100,000 individuals in Europe. Erysipelas primarily affects individuals older than 50 years, with median ages between 55 and 60 years old. Data are inconclusive with regards to the predominant gender in erysipelas patients; studies have shown both a predominance in males and females in different patient population samples.
Epidemiology and Demographics
Incidence
Research in Belgium in 2004 approximated the incidence of erysipelas to be 249 per 100,000 individuals in Europe.[1]
Age
Erysipelas primarily affects individuals older than 50 years of age.
- Research from November 1988 - October 1990 in Sweden indicated a median age of 61 years old for erysipelas patients.[2]
- Research in Greece from 1999-2002 indicated a median age of 54.5 years old for erysipelas patients.[3]
- Research in Hungary from 2001-2002 indicated a median age of 59 years old for erysipelas patients.[4]
Gender
Data are inconclusive with regards to the predominant gender in erysipelas patients.
- Studies have shown both a predominance in males and females in different patient population samples.[4][3][2]
Race
There is no racial predilection to erysipelas.
Developed and Developing Countries
There is no geographic predilection to erysipelas.
References
- ↑ Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F (2007). "Epidemiology and comorbidity of erysipelas in primary care". Dermatology (Basel). 215 (2): 118–22. doi:10.1159/000104262. PMID 17684373.
- ↑ 2.0 2.1 Eriksson, B.; Jorup-Ronstrom, C.; Karkkonen, K.; Sjoblom, A. C.; Holm, S. E. (1996). "Erysipelas: Clinical and Bacteriologic Spectrum and Serological Aspects". Clinical Infectious Diseases. 23 (5): 1091–1098. doi:10.1093/clinids/23.5.1091. ISSN 1058-4838.
- ↑ 3.0 3.1 Krasagakis K, Valachis A, Maniatakis P, Krüger-Krasagakis S, Samonis G, Tosca AD (2010). "Analysis of epidemiology, clinical features and management of erysipelas". Int. J. Dermatol. 49 (9): 1012–7. PMID 20931671.
- ↑ 4.0 4.1 Vâţă D, Solovăstru LG, Vâţă A, Dorobăţ C (2011). "[Demographic, clinical and laboratory characteristics of erisypelas in the period 2001-2010]". Rev Med Chir Soc Med Nat Iasi (in Romanian). 115 (4): 1042–7. PMID 22276443.